在患有三级/四级固体乳腺癌的狗身上进行了强化多式化疗
Claire Beaudu-Lange1, Emmanuel Lange1
1Clinique Vétérinaire de la Pierre Bleue, 35550 Pipriac, France.
Animals : an open access journal from MDPI
|September 14, 2024
概括
化学疗法对攻击性犬乳腺癌是具有挑战性的. 这份病例报告详细介绍了一项成功的密集治疗,结合了手术和调整化学疗法,实现了218天的存活期与良好的生活质量.
科学领域:
- 兽医瘤学 兽医瘤学
- 狗癌症研究 狗癌症研究
- 药理疗法 药理疗法 药理疗法
背景情况:
- 有限的证据表明,化疗对犬类侵袭性乳腺癌的疗效有限.
- 与人类医学不同的是,对于基于等级和阶段的狗乳腺瘤,缺乏标准化的治疗方案.
- 侵袭性乳腺癌在兽医瘤学中构成了重大挑战.
研究的目的:
- 描述一种针对复发性,高度犬乳腺癌的密集治疗方案.
- 评估结合手术和辅助化疗方法的疗效.
- 报告患有晚期乳腺癌的狗患者的生存率和生活质量.
主要方法:
- 一只患有淋巴侵袭的第四阶段固体乳腺癌 (三级) 的狗的病例报告.
- 进行彻底的手术,然后进行密集的辅助化疗.
- 结合最大耐受剂量卡博普拉丁与计量化学疗法 (费罗可西布,托塞拉尼布,氨基) 进行剂量调整.
主要成果:
- 强化治疗导致218天的生存.
- 在整个治疗期间,狗保持了良好的生活质量.
- 化疗剂量调整可以预防严重的不良事件.
结论:
- 这种最大耐受剂量和计量学化疗的新组合可能是对攻击性犬乳腺癌的可行选择.
- 需要在大规模前性研究中进行进一步的调查来证实这些发现.
- 这种方法为改善犬乳腺癌的结果提供了潜在的策略.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.